Advertisement

Genetron Holdings Limited GTH

Set alert

Price alert · GTH

All alert types
4.03 +4.03 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
127.29M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-25.16
Beta
0.50
Short ratio
0.29
Inst. own
12.51%
Dividend
0.00
Ex-div date
Earnings
Oct 12, 2022
50-d avg
3.87
200-d avg
3.33
1y target
0.00

3M chart

Chart tools
Interval

Signals (11)
NameDateAgo
RSI: OverboughtMar 28, 20242 years ago
MACD: Buy SignalMar 22, 20242 years ago
RSI: OverboughtMar 22, 20242 years ago
SMA: BearishMar 19, 20242 years ago
MACD: Sell SignalMar 6, 20242 years ago
MACD: Buy SignalFeb 21, 20242 years ago
RSI: OverboughtFeb 21, 20242 years ago
MACD: Sell SignalFeb 1, 20242 years ago
MACD: Buy SignalJan 18, 20242 years ago
RSI: OverboughtJan 18, 20242 years ago
SMA: BearishDec 29, 20232 years ago

Key statistics

Market cap
127.29M
Enterprise value
1.66B
Trailing P/E
0.00
Forward P/E
-25.16
PEG ratio
0.00
Price / sales
0.20
Price / book
0.22
EPS (TTM)
-3.62
Beta
0.50
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-124.24%
Revenue (TTM)
650.71M
Revenue growth
37.10%
Free cash flow
-317.70M
Total cash
338.86M
Total debt
158.57M
Return on equity
-92.20%
Shares outstanding
31.62M
Short % of float
0.00%
50-day average
3.87
200-day average
3.33

Analyst view

Consensus: buy

Buy
Price target (mean) 0.00

Next earnings

Oct 12, 2022

Expected Oct 12, 2022. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
GTH Revenue — quarterly 137.75M
2019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 2022
GTH Net income — quarterly -235.22M
2019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 2022
GTH EPS — quarterly -7.65
2019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 2022

Earnings

GTH recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Oct 12, 2022Jun 1, 20220.00———
Jun 2, 2022Mar 1, 20220.00———
Mar 29, 2022Dec 1, 20210.00———
Nov 30, 2021Sep 1, 20210.00———
Aug 24, 2021Jun 1, 20210.00———
May 24, 2021Mar 1, 20210.00———

Upgrades / downgrades

GTH analyst upgrades and downgrades
DateFirmActionFromTo
Apr 20, 2022BTIGmain—Buy
Jul 13, 2020Canaccord Genuityinit—Buy
Jul 13, 2020BTIGinit—Buy

About Genetron Holdings Limited

Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. The company also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. Genetron Holdings Limited was founded in 2013 and is headquartered in Beijing, the People's Republic of China.

Sector
Healthcare
Industry
Diagnostics & Research
Country
China

News

Your note

Sign in to keep a note on GTH — it syncs with the Stock Master app.

Institution ownership

GTH institution ownership
Holder% heldSharesValueReported
Vivo Capital, LLC8.87%8,124,1747.56MJun 29, 2023
Baker Brothers Advisors, LLC0.50%455,306423.48KJun 29, 2023
Yong Rong (HK) Asset Management Ltd0.35%322,082261.56KSep 29, 2023
Robeco Institutional Asset Management B.V.0.30%272,398253.36KJun 29, 2023
Hudson Bay Capital Management Lp0.28%253,898236.15KJun 29, 2023
Norges Bank Investment Management0.24%218,296244.49KDec 30, 2022

Fund ownership

GTH fund ownership
Holder% heldSharesValueReported
SPDR Portfolio Emerging Markets ETF0.04%34,38032.88KAug 30, 2023
Fidelity NASDAQ Composite Index Fund0.01%12,26211.04KMay 30, 2023
Advertisement